Company
Headquarters: Beihai, China
Employees: 443
CN¥2.86 Billion
CNY as of Jan. 1, 2025
US$391.4 Million
| Company | Market Cap (USD) |
|---|---|
| Corteva, Inc. | $44.12 B |
| Nutrien Ltd. | $22.05 B |
| CF Industries Holdings, Inc. | $16.57 B |
| SABIC Agri-Nutrients Company | $14.22 B |
| The Mosaic Company | $9.15 B |
| Company | Market Cap (USD) |
|---|---|
| Linde | $209.90 B |
| BHP | $151.21 B |
| Rio Tinto | $102.04 B |
| Air Liquide SA | $97.26 B |
| The Sherwin-Williams Company | $90.95 B |
Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eyesight eye drops, gastrointestinal granules, pearl powder, and other proprietary Chinese medicines. It also provides molecular medical imaging and tumor radiotherapy centers, as well as tumor telemedicine technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in May 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was founded in 1993 is based in Beihai, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Beihai Gofar Marine Biological Industry Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600538 wb_incandescent